The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
What is the optimum interval between mammographic screening examinations — An analysis based on the latest results of the Swedish two-county breast cancer screening trial
Open accessAbstract
Further results are presented from the Swedish two-county breast cancer screening trial. The reduction in the rate of advanced cancers and of breast cancer mortality in the group allocated to screening when compared to the control group has accelerated with a further year of follow-up. Mortality due to other causes and the rate of other cancers remains similar in the two groups. Attention has been focused on the rate at which cancers start re-emerging among women with negative mammograms. Among women over 50 years of age at entry to the study, relatively few interval cancers are seen in the first two years after a screening test; in the third year the rate rises to nearly 50% of the comparable rate in the control group. Among women aged 40-49 years at entry, by contrast, the rate of interval cancers even in the first post screening year is nearly 40% of that in the controls and in the second year nearly 70%. In older women in the group allocated to screening, much of the breast cancer mortality comes from the refusers and little from the interval cancers; in younger women the picture is reversed. The implications for screening policy, including the interscreening interval are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHY
Tabár, L., Gad, A., Holmberg, L. H., Ljungquist, U., Fagerberg, C. J. G., Baldetorp, L., Gröntoft, O., Lundström, B., Månson, J. C., Eklund, G., et al. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92204-4 · Cited by 1,781
Self-citationTen- to Fourteen-Year Effect of Screening on Breast Cancer Mortality 2
(1982) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/69.2.349 · Cited by 840
REDUCTION OF BREAST CANCER MORTALITY THROUGH MASS SCREENING WITH MODERN MAMMOGRAPHY
Verbeek, A. L. M., Holland, R., Sturmans, F., Hendriks, J. H. C. L., Avunac, M., & Day, N. E. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91703-3 · Cited by 495
Self-citation
Cited by
Screening for breast cancer with mammography
Gøtzsche, P. C., & Jørgensen, K. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub5 · Cited by 1,869
Oeffinger, K. C., Fontham, E. T. H., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y.-C. T., Walter, L. C., Church, T. R., Flowers, C. R., LaMonte, S. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.12783 · Cited by 1,653
Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force
Humphrey, L. L., Helfand, M., Chan, B. K. S., & Woolf, S. H. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_1-200209030-00012 · Cited by 1,137
American Cancer Society Guidelines for Breast Cancer Screening: Update 2003
Smith, R. A., Saslow, D., Andrews Sawyer, K., Burke, W., Costanza, M. E., Evans, W. P., Foster, R. S., Hendrick, E., Eyre, H. J., & Sener, S. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.3.141 · Cited by 770
UPDATE OF THE SWEDISH TWO-COUNTY PROGRAM OF MAMMOGRAPHIC SCREENING FOR BREAST CANCER
Tabàr, L., Fagerberg, G., Duffy, S. W., Day, N. E., Gad, A., & Gröntoft, O. (1992) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(22)02494-0 · Cited by 731
Self-citation
Metadata
- Authors
- Tabár, L., Faberberg, G., Day, N., & Holmberg, L.
- Venue
- British Journal of Cancer
- Published
- 1987-05
- Volume
- 55
- Issue
- 5
- Pages
- 547-551
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2059773982
- Cited by
- 318
- References
- 3
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: What is the optimum interval between mammographic screening examinations — An analysis based on the latest results of the Swedish two-county breast cancer screening trial. https://app.cochat.ai/papers/10.1038/bjc.1987.112
- The paper
- Tabár, L., Faberberg, G., Day, N., & Holmberg, L. (1987). What is the optimum interval between mammographic screening examinations — An analysis based on the latest results of the Swedish two-county breast cancer screening trial. British Journal of Cancer. https://doi.org/10.1038/bjc.1987.112
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.